New selectable marker for manipulating the simple genomes of Mycoplasma species.
Over the past several years, significant advances have been made in the molecular genetics of the Mollicutes (the simplest cells that can be grown in axenic culture). Nevertheless, a number of basic molecular tools are still required before genetic manipulations become routine. Here we describe the development of a new dominant selectable marker based on the enzyme puromycin-N-acetyltransferase from Streptomyces alboniger. Puromycin is an antibiotic that mimics the 3'-terminal end of aminoacylated tRNAs and attaches to the carboxyl terminus of growing protein chains. This stops protein synthesis. Because puromycin conscripts rRNA recognition elements that are used by all of the various tRNAs in a cell, it is unlikely that spontaneous antibiotic resistance can be acquired via a simple point mutation--an annoying issue with existing mycoplasma markers. Our codon-optimized cassette confers pronounced puromycin resistance on all five of the mycoplasma species we have tested so far. The resistance cassette was also designed to function in Escherichia coli, which simplifies the construction of shuttle vectors and makes it trivial to produce the large quantities of DNA generally necessary for mycoplasma transformation. Due to these and other features, we expect the puromycin marker to be a widely applicable tool for studying these simple cells and pathogens.
Algire
Mikkel A
MA
The J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, Maryland 20850, USA.
Lartigue
Carole
C
Thomas
David W
DW
Assad-Garcia
Nacyra
N
Glass
John I
JI
Merryman
Chuck
C
D000123:Acetyltransferases / Q000235:genetics; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016680:Genome, Bacterial / Q000235:genetics*; D008957:Models, Genetic; D009174:Mycoplasma / Q000187:drug effects / Q000235:genetics*; D011691:Puromycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011691:Puromycin; D000123:Acetyltransferases; C045336:puromycin N-acetyltransferase
Plasmid. 1994 May;31(3):308-11
8058824
Microbiology (Reading). 2006 Feb;152(Pt 2):519-527
16436439
Nucleic Acids Res. 1981 Aug 11;9(15):3641-6
6169010
Plasmid. 2002 Sep;48(2):149-59
12383732
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):425-30
16407165
Science. 2008 Feb 29;319(5867):1215-20
18218864
Int J Syst Evol Microbiol. 2009 Jun;59(Pt 6):1353-8
19502315
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5589-93
2198567
J Bacteriol. 1985 Dec;164(3):1094-9
2999069
Plasmid. 1991 Sep;26(2):108-15
1661012
Nat Methods. 2007 Mar;4(3):251-6
17293868
Science. 1977 Mar 4;195(4281):892-4
841314
Science. 1999 Dec 10;286(5447):2165-9
10591650
Infect Immun. 2000 Dec;68(12):6643-9
11083776
FEMS Immunol Med Microbiol. 1996 Oct;15(4):199-211
8908481
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15440-5
14657399
Cell. 2004 May 28;117(5):589-99
15163407
Mol Microbiol. 2003 Nov;50(4):1199-213
14622409
Front Biosci. 2007 Jan 01;12:2020-8
17127440
Science. 2007 Aug 3;317(5838):632-8
17600181
Plasmid. 1993 Sep;30(2):170-5
8234492
Plasmid. 2002 Mar;47(2):129-37
11982334
Nucleic Acids Res. 2003 Nov 15;31(22):6610-8
14602921
J Bacteriol. 1994 Jul;176(14):4459-62
8021232